Following Centene’s (CNC) withdrawal of FY25 guidance after the close yesterday, JPMorgan noted that Centene has the largest relative exposure in the analyst’s coverage universe to the ACA Exchanges and pointed out that several Managed Care Organizations have already flagged utilization pressures and shifts in risk pools in their ACA Exchange books. The firm sees all of this as an indication that the relative health of the ACA Exchange risk pool has deteriorated in 2025, but it believes that it is “too early to conclude” that other MCOs are exposed to a similar risk as Centene and it is “apprehensive about extrapolating” Centene’s challenges to the broader MCO group with smaller exposures across the group, the analyst tells investors. Shares of a number of other MCO names are trading lower in early Wednesday trading following Centene’s guidance withdrawal and warning.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNC:
- Centene price target lowered to $52 from $65 at BofA
- Centene price target lowered to $45 from $65 at Barclays
- Centene’s Financial Outlook Challenged by Marketplace and Medicaid Trends, Hold Rating Issued
- Centene price target lowered to $65 from $90 at Cantor Fitzgerald
- Centene downgraded to Neutral from Overweight at JPMorgan
